Special circumstances may toll or extend limitation periods, including minority status for patients under 18, mental incapacity preventing awareness of legal rights, fraudulent concealment by the manufacturer, or continuous treatment doctrine in some jurisdictions
Additionally, type 2 diabetes can disrupt hormone levels that influence the hair growth cycle
In contrast, the present study focuses exclusively on RCTs that directly compare at least two GLP-1 receptor agonists as monotherapies
Additional metabolic investigations, including fasting glucose, HbA1c, and lipid profiles, can help assess overall metabolic health
In the U.S., semaglutide is already approved and widely available: Wegovy for chronic weight management Ozempic for type 2 diabetes Semaglutide is the drug that made GLP-1 weight-loss treatment mainstream